Feed CTTH
CT
CTT Pharmaceutical Holdings, Inc.
CTTH · OTC
$0.06 -2.52% (-$0.00)
1M -5.67%
Market Cap $3.58M
P/E Ratio -
Div. Yield -
ROE 242.12%
Bulios Fair Price
$0.04
33.2% downside
Current Price
$0.06
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CTTH is currently overvalued relative to its market price. How does it work?
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/B 86.67x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 14.82%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 192.52%
ROE 242.12%
ROA 206.81%
Debt
40 /100
Moderate Debt/Equity 0.46x
Current ratio 0.20x
Int. coverage -57.73x
Stability
37 /100
Moderate Beta 0.77x
EPS volatility 240.48%
Profitable years 0
Ask StockBot about CTTH
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Ryan Khouri
Employees
1
Headquarters
Tampa